Dermatology
News
FDA approves Yuflyma as ninth adalimumab biosimilar
The manufacturer Celltrion is also seeking an interchangeability designation from the FDA, tentatively expected in the fourth quarter of 2024.
News
FDA approves autoinjector pen for Humira biosimilar, Cyltezo
The drug will be commercially available on July 1, 2023.
News
AD in infancy: Diagnostic advice and treatment tips
Among infants who are growing well and otherwise healthy, the infantile eczema phenotype encompasses AD, seborrheic dermatitis, contact dermatitis...
Opinion
Expunging ‘penicillin allergy’: Your questions answered
Great to hear the enthusiasm for testing for penicillin allergy!
News
CDC: Drug-resistant ringworm reported in New York
BY ALICIA AULT
The
News
Facial, hand, and foot dermatitis: Lebrikizumab and dupilumab show efficacy in new studies
"Lebrikizumab was efficacious in clearing and improving facial and hand dermatitis, burdensome and difficult-to-treat areas, in most patients," Dr...
News
Cutaneous vasculitis curtails quality of life
Survey respondents described a generally poor health-related quality of life that was detailed as more severe with a skin-specific instrument than...
Conference Coverage
Can this tool forecast peanut allergies?
The predictive scorecard captures 14 images from one infant of mixed race, two White infants, two Black infants, and two Hispanic infants.
News
Two phase 3 trials show benefits of dupilumab for prurigo nodularis
The results “support the involvement of type 2 cytokines in driving PN disease pathogenesis and the targeting of the IL-4/IL-13 axis as a novel...
News
Study shifts burden of IgG4-related disease to women
First population-based U.S. analysis establishes “key benchmarks” for immune-mediated condition initially described in 2001.